1 day ago
Akari Therapeutics (AKTX) Stock Skyrockets 120% on Promising Cancer Drug Results
Akari Therapeutics (AKTX) stock soared 120% after-hours on preclinical data showing AKTX-101 works synergistically with adagrasib in pancreatic cancer models.
The post Akari Therapeutics (AKTX) Stock Skyrockets 120% on Promising Cancer Drug Results appeared first on Blockonomi.
Source: Blockonomi →Related News
- 12 hours ago
Hewlett Packard Enterprise (HPE) Stock Soars to Record Peak as Elliott Expands P...
- 12 hours ago
Norwegian Cruise Line (NCLH) Stock Plummets 9.5% — Company Insiders Buy Big
- 12 hours ago
Dell (DELL) Stock Rockets 16% to All-Time Peak Ahead of May 28 Earnings
- 12 hours ago
BlackBerry (BB) Stock Surges 19% to New 52-Week Peak on Bullish Outlook
- 12 hours ago
Navitas Semiconductor (NVTS) Stock Soars 20% as AI Power Shift Fuels Rally
